|

Study of the Impact of PROximity Support for Patients With Type 1 DIABetes Treated With an Insulin Pump or Closed Loop.

RECRUITINGN/ASponsored by timkl
Actively Recruiting
PhaseN/A
Sponsortimkl
Started2023-09-04
Est. completion2026-10
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

Amidst medical innovations, many Type 1 diabetes patients using advanced therapy show improved control but still suffer from diabetes-related distress. To tackle this, the investigators propose an "enhanced care" model involving healthcare providers and pharmacists. The study compares standard and enhanced care for Type 1 adults, focusing on the pharmacist's role. The main question it aims to answer is : In patients with type 1 diabetes treated with pump or closed-loop therapy, does the improved enhanced care versus conventional layout improve diabetes-related distress at 12 months? Participants will complete a monthly online questionnaire to assess their diabetes-related distress as well as their frequency of use of standard and enhanced care as well as the associated patient satisfaction.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Be an adult (age ≥ 18 years)
* Have Type 1 diabetes
* Have been on closed-loop or insulin pump therapy for ≥ 6 months
* Be in moderate or high diabetes-related distress defined as a DDS2 score ≥ 6
* Be able to understand and complete questionnaires in French
* Be affiliated to the general French Social Security system
* Have an e-mail address
* Have a cell phone number

Non-inclusion criteria:

* Be deprived of liberty, under guardianship or curatorship
* Not have Internet access or a cell phone
* Have benefited or are already benefiting from the Enhanced Care program
* Participating in an interventional study on a medical device for diabetes (pump, sensors, etc.)
* Patients who are not regularly monitored in the investigating center proposing to include them, or who are likely to change centers or move to a different living area (pharmacy) within a year of inclusion.

Conditions2

DiabetesDiabetes Mellitus, Type 1

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.